(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.36%) $0.927
(0.75%) $10.85
(0.11%) $0.792
(0.15%) $92.58
5 days till quarter result
(bmo 2024-04-02)
Expected move: +/- 9.80%
Live Chart Being Loaded With Signals
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases...
Stats | |
---|---|
Today's Volume | 5 349.00 |
Average Volume | 28 144.00 |
Market Cap | 28.28M |
EPS | $0 ( 2023-12-05 ) |
Next earnings date | ( $-0.260 ) 2024-04-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.569 |
ATR14 | $0.0640 (0.99%) |
Volume Correlation
Freeline Therapeutics Correlation
10 Most Positive Correlations | |
---|---|
INVZ | 0.906 |
VEEE | 0.895 |
PSTV | 0.891 |
ISUN | 0.891 |
COMM | 0.889 |
MTCH | 0.887 |
DIBS | 0.886 |
BBIG | 0.884 |
ICCC | 0.879 |
NEGG | 0.877 |
10 Most Negative Correlations | |
---|---|
TYHT | -0.846 |
RAM | -0.825 |
SVFC | -0.82 |
CPTA | -0.816 |
ALDX | -0.807 |
SCR | -0.804 |
VERX | -0.803 |
EBSB | -0.803 |
AAON | -0.802 |
BLCT | -0.801 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Freeline Therapeutics Correlation - Currency/Commodity
Freeline Therapeutics Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $-1.74M (0.00 %) |
EPS: | $-22.52 |
Q3 | 2023 |
Revenue: | $5 000.00 |
Gross Profit: | $-378 759 (-7 575.18 %) |
EPS: | $-2.77 |
Q2 | 2023 |
Revenue: | $617 000 |
Gross Profit: | $182 608 (29.60 %) |
EPS: | $-3.69 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $-322 903 (0.00 %) |
EPS: | $0.300 |
Financial Reports:
No articles found.
Freeline Therapeutics
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in Phase 1/2 clinical trials in adult males for the treatment of hemophilia B. The company's products also include FLT190, which is in Phase 1/2 clinical trial for the treatment of Fabry disease; and FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease and is under Phase 1/2 clinical trial. In addition, it has research programs in various indications for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators